Alnylam Pharmaceuticals Inc (ALNY)
273.91
+7.32
(+2.75%)
USD |
NASDAQ |
Nov 01, 16:00
273.75
-0.16
(-0.06%)
After-Hours: 20:00
Alnylam Pharmaceuticals Total Liabilities (Quarterly): 4.173B for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 4.173B |
| June 30, 2024 | 4.013B |
| March 31, 2024 | 4.044B |
| December 31, 2023 | 4.051B |
| September 30, 2023 | 4.005B |
| June 30, 2023 | 3.811B |
| March 31, 2023 | 3.651B |
| December 31, 2022 | 3.705B |
| September 30, 2022 | 3.603B |
| June 30, 2022 | 3.154B |
| March 31, 2022 | 3.032B |
| December 31, 2021 | 3.055B |
| September 30, 2021 | 2.716B |
| June 30, 2021 | 2.656B |
| March 31, 2021 | 2.329B |
| December 31, 2020 | 2.391B |
| September 30, 2020 | 2.092B |
| June 30, 2020 | 1.975B |
| March 31, 2020 | 929.90M |
| December 31, 2019 | 956.44M |
| September 30, 2019 | 934.54M |
| June 30, 2019 | 959.22M |
| March 31, 2019 | 467.01M |
| December 31, 2018 | 272.84M |
| September 30, 2018 | 197.54M |
| Date | Value |
|---|---|
| June 30, 2018 | 168.59M |
| March 31, 2018 | 168.33M |
| December 31, 2017 | 228.30M |
| September 30, 2017 | 299.45M |
| June 30, 2017 | 311.32M |
| March 31, 2017 | 303.02M |
| December 31, 2016 | 342.59M |
| September 30, 2016 | 297.94M |
| June 30, 2016 | 283.68M |
| March 31, 2016 | 127.90M |
| December 31, 2015 | 121.80M |
| September 30, 2015 | 114.54M |
| June 30, 2015 | 122.17M |
| March 31, 2015 | 132.28M |
| December 31, 2014 | 143.33M |
| September 30, 2014 | 81.88M |
| June 30, 2014 | 90.39M |
| March 31, 2014 | 125.32M |
| December 31, 2013 | 150.18M |
| September 30, 2013 | 149.92M |
| June 30, 2013 | 154.38M |
| March 31, 2013 | 160.02M |
| December 31, 2012 | 153.47M |
| September 30, 2012 | 145.19M |
| June 30, 2012 | 130.19M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
929.90M
Minimum
Mar 2020
4.173B
Maximum
Sep 2024
3.017B
Average
3.105B
Median
Total Liabilities (Quarterly) Benchmarks
| Pfizer Inc | 128.22B |
| Regeneron Pharmaceuticals Inc | 8.116B |
| BridgeBio Pharma Inc | 1.876B |
| Biomarin Pharmaceutical Inc | 1.438B |
| Johnson & Johnson | 108.13B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 4.205B |
| Shareholders Equity (Quarterly) | 32.35M |
| Debt to Equity Ratio | 31.64 |
| Current Ratio | 2.749 |
| Net Debt Paydown Yield | -0.00% |